These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28477351)

  • 1. Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests.
    Saccà F; Costabile T; Abate F; Liguori A; Paciello F; Pane C; De Rosa A; Manganelli F; De Michele G; Filla A
    J Neuropsychol; 2018 Sep; 12(3):471-483. PubMed ID: 28477351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy.
    Costabile T; Pane C; Aurisicchio L; Salvati A; Lieto M; Peluso S; Reia A; De Lucia N; De Rosa A; Filla A; De Michele G; Saccà F
    Neurol Sci; 2020 Dec; 41(12):3633-3641. PubMed ID: 32462388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an objective evaluating system to quantify the degree of upper limb movement impairment in patients with severe Friedreich's ataxia.
    Arcuria G; Marcotulli C; Amuso R; Dattilo G; Galasso C; Pierelli F; Casali C
    Neurol Sci; 2020 Jun; 41(6):1577-1587. PubMed ID: 31993871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of three measures of upper limb function in Friedreich ataxia.
    Corben LA; Tai G; Wilson C; Collins V; Churchyard AJ; Delatycki MB
    J Neurol; 2010 Apr; 257(4):518-23. PubMed ID: 19823893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does performance of the Friedreich Ataxia Functional Composite compare to rating scales?
    Tai G; Yiu EM; Delatycki MB; Corben LA
    J Neurol; 2017 Aug; 264(8):1768-1776. PubMed ID: 28695363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring Inhibition and Cognitive Flexibility in Friedreich Ataxia.
    Corben LA; Klopper F; Stagnitti M; Georgiou-Karistianis N; Bradshaw JL; Rance G; Delatycki MB
    Cerebellum; 2017 Aug; 16(4):757-763. PubMed ID: 28229372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction.
    Corben LA; Delatycki MB; Bradshaw JL; Horne MK; Fahey MC; Churchyard AJ; Georgiou-Karistianis N
    J Neurol; 2010 May; 257(5):782-91. PubMed ID: 19957189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voice in Friedreich Ataxia.
    Vogel AP; Wardrop MI; Folker JE; Synofzik M; Corben LA; Delatycki MB; Awan SN
    J Voice; 2017 Mar; 31(2):243.e9-243.e19. PubMed ID: 27501923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.
    Friedman LS; Farmer JM; Perlman S; Wilmot G; Gomez CM; Bushara KO; Mathews KD; Subramony SH; Ashizawa T; Balcer LJ; Wilson RB; Lynch DR
    Mov Disord; 2010 Mar; 25(4):426-32. PubMed ID: 20063431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral measures of the effects of Friedreich's ataxia on speech.
    Rosen KM; Folker JE; Murdoch BE; Vogel AP; Cahill LM; Delatycki MB; Corben LA
    Int J Speech Lang Pathol; 2011 Aug; 13(4):329-34. PubMed ID: 21062121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition in Friedreich ataxia.
    Nieto A; Correia R; de Nóbrega E; Montón F; Hess S; Barroso J
    Cerebellum; 2012 Dec; 11(4):834-44. PubMed ID: 22351352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological test performance of patients with Friedreich's ataxia.
    Wollmann T; Barroso J; Monton F; Nieto A
    J Clin Exp Neuropsychol; 2002 Aug; 24(5):677-86. PubMed ID: 12187450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult normative values for the PATA Rate Test.
    Pane C; Costabile T; Salvati A; Aurisicchio DL; Abate F; Liguori A; Paciello F; Peluso S; Manganelli F; De Michele G; Filla A; Saccà F
    J Neurol; 2018 May; 265(5):1102-1105. PubMed ID: 29511862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Friedreich ataxia: complementary features of examination and performance measures.
    Lynch DR; Farmer JM; Tsou AY; Perlman S; Subramony SH; Gomez CM; Ashizawa T; Wilmot GR; Wilson RB; Balcer LJ
    Neurology; 2006 Jun; 66(11):1711-6. PubMed ID: 16769945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysarthria in Friedreich disease.
    Gentil M
    Brain Lang; 1990 Apr; 38(3):438-48. PubMed ID: 2346881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasality in Friedreich ataxia.
    Poole ML; Wee JS; Folker JE; Corben LA; Delatycki MB; Vogel AP
    Clin Linguist Phon; 2015 Jan; 29(1):46-58. PubMed ID: 25207996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical measures of dysarthria in Friedreich Ataxia.
    Singh A; Epstein E; Myers LM; Farmer JM; Lynch DR
    Mov Disord; 2010 Jan; 25(1):108-11. PubMed ID: 20014117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label pilot study of oral methylprednisolone for the treatment of patients with friedreich ataxia.
    Patel M; Schadt K; McCormick A; Isaacs C; Dong YN; Lynch DR
    Muscle Nerve; 2019 Nov; 60(5):571-575. PubMed ID: 31206761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired inhibition of prepotent motor tendencies in Friedreich ataxia demonstrated by the Simon interference task.
    Corben LA; Akhlaghi H; Georgiou-Karistianis N; Bradshaw JL; Egan GF; Storey E; Churchyard AJ; Delatycki MB
    Brain Cogn; 2011 Jun; 76(1):140-5. PubMed ID: 21354685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of the Friedreich Ataxia Impact Scale.
    Tai G; Yiu EM; Corben LA; Delatycki MB
    J Neurol Sci; 2015 May; 352(1-2):53-7. PubMed ID: 25840637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.